Physician profile
Robert M Eisner
NPI 1841372299
$12,039.54
in general payments reported to CMS, 2019-2025
6 companies · $2,130 in 2025
The $2,130 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $450 · 2022: $6,424 · 2023: $3,036 · 2025: $2,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,130 · Food and Beverage: $19.75 · Education: $15.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,130.00 |
| Food and Beverage | $19.75 |
| Education | $15.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kite Pharma, INC. | $6,423.85 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $2,145.94 | 2023-2025 | Abilify |
| Beigene USA, INC. | $1,650.00 | 2023 | Brukinsa |
| Janssen Biotech, INC. | $1,350.00 | 2023 | Tecvayli |
| Beigene, LTD. | $450.00 | 2020 | |
| Abbvie INC. | $19.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Eisner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.